These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22968142)

  • 1. Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire.
    Finger RP; Fenwick E; Pesudovs K; Marella M; Lamoureux EL; Holz FG
    Ophthalmology; 2012 Nov; 119(11):2351-7. PubMed ID: 22968142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.
    Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
    Qual Life Res; 2017 Jan; 26(1):183-191. PubMed ID: 27614659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.
    Finger RP; Guymer RH; Gillies MC; Keeffe JE
    Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine.
    Finger RP; Hoffmann AE; Fenwick EK; Wolf A; Kampik A; Kernt M; Neubauer AS; Hirneiss C
    Br J Ophthalmol; 2012 Jul; 96(7):997-1002. PubMed ID: 22535331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual functioning and quality of life under low luminance: evaluation of the German Low Luminance Questionnaire.
    Finger RP; Fenwick E; Owsley C; Holz FG; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8241-9. PubMed ID: 21908584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.
    Mitchell J; Wolffsohn J; Woodcock A; Anderson SJ; Ffytche T; Rubinstein M; Amoaku W; Bradley C
    Am J Ophthalmol; 2008 Sep; 146(3):447-454. PubMed ID: 18547542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the severity of vision loss on vision-related quality of life in India: an evaluation of the IND-VFQ-33.
    Finger RP; Kupitz DG; Holz FG; Balasubramaniam B; Ramani RV; Lamoureux EL; Fenwick E
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6081-8. PubMed ID: 21693607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis.
    Khadka J; Pesudovs K; McAlinden C; Vogel M; Kernt M; Hirneiss C
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6971-7. PubMed ID: 21810983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration.
    Frennesson C; Nilsson UL; Peebo BB; Nilsson SE
    Acta Ophthalmol; 2010 Jun; 88(4):420-5. PubMed ID: 19678811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of vision impairment on vision-specific quality of life in Germany.
    Finger RP; Fenwick E; Marella M; Dirani M; Holz FG; Chiang PP; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3613-9. PubMed ID: 21357395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste.
    du Toit R; Palagyi A; Ramke J; Brian G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision and Quality of Life Index: validation of the Indian version using Rasch analysis.
    Gothwal VK; Bagga DK
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4871-81. PubMed ID: 23800765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life.
    Mitchell J; Wolffsohn JS; Woodcock A; Anderson SJ; McMillan CV; Ffytche T; Rubinstein M; Amoaku W; Bradley C
    Health Qual Life Outcomes; 2005 Apr; 3():25. PubMed ID: 15831093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
    Maguire M;
    Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocol.
    Finger RP; Tellis B; Crewe J; Keeffe JE; Ayton LN; Guymer RH
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6150-8. PubMed ID: 25190656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Vision Impairment for Children (IVI_C): validation of a vision-specific pediatric quality-of-life questionnaire using Rasch analysis.
    Cochrane GM; Marella M; Keeffe JE; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1632-40. PubMed ID: 21178144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study).
    Nguyen QD; Schachar RA; Nduaka CI; Sperling M; Klamerus KJ; Chi-Burris K; Yan E; Paggiarino DA; Rosenblatt I; Aitchison R; Erlich SS;
    Ophthalmology; 2012 Sep; 119(9):1867-73. PubMed ID: 22683252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
    Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.